Minimally Invasive Transforaminal Lumbar Interbody Fusion for Osteogenesis Imperfecta: A Case Report
Vol. 45 No. 3 (2026), Case Report
Vol. 45 No. 3 (2026)

Minimally Invasive Transforaminal Lumbar Interbody Fusion for Osteogenesis Imperfecta: A Case Report

Case Report
Published 2026-09-24
  • Gabriel Gonzalez-Diaz
  • John Muñoz
  • Natalie Figueroa
  • Emil Varas-Rodríguez
  • Karl Vega
  • Oscar Duyos
Gabriel Gonzalez-Diaz
John Muñoz
Natalie Figueroa
Emil Varas-Rodríguez
Karl Vega
Oscar Duyos
PDF

Keywords

Osteogenesis Imperfecta
Spinal Stenosis
Robotic Surgical Procedures
Transforaminal Lumbar Interbody Fusion
Minimally Invasive Surgical Procedures

How to Cite

Gonzalez-Diaz, G., Muñoz, J., Figueroa, N., Varas-Rodríguez, E., Vega, K., & Duyos, O. (2026). Minimally Invasive Transforaminal Lumbar Interbody Fusion for Osteogenesis Imperfecta: A Case Report. Puerto Rico Health Sciences Journal, 45(3), 193–196. Retrieved from https://prhsj.rcm.upr.edu/index.php/prhsj/article/view/3564
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Abstract

This case report describes the use of minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF) in a patient with osteogenesis imperfecta (OI). A 59-year-old woman with significant spinal stenosis and anterolisthesis at L4–L5 underwent MIS-TLIF due to a lack of improvement with conservative measures. Preoperative planning was key, as the patient’s dual-energy X-ray absorptiometry scan revealed osteopenia. The procedure was completed without intraoperative or postoperative complications; nerve root decompression resulted in significant symptomatic improvement. At 1-year follow-up, the patient had no axial or radicular pain, full motor strength, and no evidence of cage subsidence or pedicle screw loosening. This case highlights the feasibility of MIS-TLIF in a patient with OI and underscores the importance of meticulous preoperative planning and advanced imaging techniques to ensure safety and efficacy in patients with connective tissue disorders.

PDF
Authors who publish with this journal agree to the following terms: a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).